Inobrodib (CCS1477)

Inobrodib · CellCentric Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Inobrodib (CCS1477), covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies [Phase 1, Phase 2]